Immunitybio executive chairman dr. patrick soon-shiong delivers the packard lecture at uniformed services university

Culver city, calif.--(business wire)--immunitybio, inc. (nasdaq: ibrx), a clinical-stage immunotherapy company, today announced that executive chairman and global chief scientific and medical officer patrick soon-shiong, m.d., has been invited to deliver the 2023 david packard award lecture at the uniformed services university of the health sciences (usu). the university extended dr. soon-shiong the invitation to give this prestigious guest lecture in recognition of his “scientific accomplishme.
IBRX Ratings Summary
IBRX Quant Ranking